Polymorphisms in the lymphotoxin alpha gene and the risk of ischemic stroke in the Japanese population: The Fukuoka Stroke Registry and the Hisayama Study

Cerebrovascular Diseases

Volumn 25, Issue 5, 2008, Pages 417-422

  Hagiwara, Noriko ^a   Kitazono, Takanari ^a   Kamouchi, Masahiro ^a   Kuroda, Junya ^a,b   Ago, Tetsuro ^a   Hata, Jun ^a   Ninomiya, Toshiharu ^a   Ooboshi, Hiroaki ^a   Kumai, Yasuhiro ^a   Yoshimura, Sohei ^a   Tamaki, Kinya ^c   Fujii, Kenichiro ^d   Nagao, Tetsuhiko ^e   Okada, Yasushi ^f   Toyoda, Kazunori ^f   Nakane, Hiroshi ^g   Sugimori, Hiroshi ^g   Yamashita, Yoshichika ^b   Wakugawa, Yoshiyuki ^a   Kubo, Michiaki ^a   Tanizaki, Yumihiro ^a   Kiyohara, Yutaka ^a   Ibayashi, Setsuro ^a   Iida, Mitsuo ^a   more..

^a KYUSHU UNIVERSITY   (Japan)

^b Seiai Rehabilitation Hospital   (Japan)

^c Hakujyuji Hospital   (Japan)

^d FUKUOKA RED CROSS HOSPITAL   (Japan)

^e Imazu Sekijuji Hospital   (Japan)

^f NATIONAL HOSPITAL ORGANIZATION   (Japan)

^g FUKUOKA HIGASHI MEDICAL CENTER   (Japan)

Author keywords

Atherosclerosis; Inflammation; Ischemic stroke; Lymphotoxin ; Polymorphism

Indexed keywords

FLUORESCENT DYE; LYMPHOTOXIN;

ADULT; AGED; ALLELE; ARTICLE; CASE CONTROL STUDY; CEREBROVASCULAR ACCIDENT; CONTROLLED STUDY; FEMALE; GENE FREQUENCY; GENETIC ASSOCIATION; GENETIC POLYMORPHISM; GENOTYPE; HUMAN; JAPANESE; LOGISTIC REGRESSION ANALYSIS; MAJOR CLINICAL STUDY; MALE; POLYMERASE CHAIN REACTION; POPULATION GENETICS; PRIORITY JOURNAL; REGISTER; RISK FACTOR;

AGED; AGED, 80 AND OVER; ASIAN CONTINENTAL ANCESTRY GROUP; BRAIN ISCHEMIA; CASE-CONTROL STUDIES; COHORT STUDIES; FEMALE; GENE FREQUENCY; HUMANS; JAPAN; LYMPHOTOXIN-ALPHA; MALE; MIDDLE AGED; POLYMORPHISM, GENETIC; REGISTRIES; STROKE;

EID: 44449118037     PISSN: 10159770     EISSN: None     Source Type: Journal    
DOI: 10.1159/000121342     Document Type: Article

References (21)

1. Ross R: Atherosclerosis - an inflammatory disease. N Engl J Med 1999;340:115-126.
2. Cope AP: Regulation of autoimmunity by proinflammatory cytokines. Curr Opin Immunol 1998;10:669-676.
3. Shimamoto T, Komachi Y, Inada H, Doi M, Iso H, Sato S, Kitamura A, Iida M, Konishi M, Nakanishi N, Terao A, Naito Y, Kojima S: Trends for coronary heart disease and stroke and their risk factors in Japan. Circulation 1989;79:503-515.
4. Ozaki K, Ohnishi Y, Iida A, Sekine A, Yamada R, Tsunoda T, Sato H, Sato H, Hori M, Nakamura Y, Tanaka T: Functional SNPs in the lymphotoxin-alpha gene that are associated with susceptibility to myocardial infarction. Nat Genet 2002;32:650-654.
5. Keso T, Perola M, Lappala P, Ilveskoski E, Kunnas TA, Mikkelsson J, Penttila A, Hurme M, Karhunen PJ: Polymorphisms within the tumor necrosis factor locus and prevalence of coronary artery disease in middle-aged men. Atherosclerosis 2001;154:691-697.
6. Yamada A, Ichihara S, Murase Y, Kato T, Izawa H, Nagata K, Murohara T, Yamada Y, Yokota M: Lack of association of polymorphisms of the lymphotoxin alpha gene with myocardial infarction in Japanese. J Mol Med 2004;82:477-483.
7. Kimura A, Takahashi M, Choi BY, Bae SW, Hohta S, Sasaoka T, Nakahara KI, Chida K, Sawabe M, Yasunami M, Naruse T, Izumi T, Park JE: Lack of association between LTA and LGALS2 polymorphisms and myocardial infarction in Japanese and Korean populations. Tissue Antigens 2007;69:265-269.
8. Tobin MD, Braund PS, Burton PR, Thompson JR, Steeds R, Channer K, Cheng S, Lindpaintner K, Samani NJ: Genotypes and haplotypes predisposing to myocardial infarction: a multilocus case-control study. Eur Heart J 2004;25:459-467.
9. Clarke R, Xu P, Bennett D, Lewington S, Zondervan K, Parish S, Palmer A, Clark S, Cardon L, Peto R, Lathrop M, Collins R, International Study of Infarct Survival (ISIS) Collaborators: Lymphotoxin-alpha gene and risk of myocardial infarction in 6,928 cases and 2,712 controls in the ISIS case-control study. PLoS Genet 2006;2:990-996.
10. Um JY, An NH, Kim HM: TNF-alpha and TNF-beta gene polymorphisms in cerebral infarction. J Mol Neurosci 2003;21:167-171.
11. phox C242T polymorphism and ischemic stroke in Japan: the Fukuoka Stroke Registry and the Hisayama Study. Eur J Neurol 2007;14:1091-1097.
12. Tanizaki Y, Kiyohara Y, Kato I, Iwamoto H, Nakayama K, Shinohara N, Arima H, Tanaka K, Ibayashi S, Fujishima M: Incidence and risk factors for subtypes of cerebral infarction in a general population: the Hisayama Study. Stroke 2000;31:2616-2622.
13. Special report from the National Institute of Neurological Disorders and Stroke: classification of cerebrovascular diseases III. Stroke 1990;21:637-676.
14. Cerebral Embolism Task Force: Cardiogenic brain embolism. Arch Neurol 1986;43:71-84.
15. Adams HP Jr, Bendixen BH, Kappelle LJ, Biller J, Love BB, Gordon DL, Marsh EE 3rd: Classification of subtype of acute ischemic stroke: definitions for use in a multicenter clinical trial. Trial of Org 10172 in Acute Stroke Treatment. Stroke 1993;24:35-41.
16. Bernard PS, Reiser A, Pritham GH: Mutation detection by fluorescent hybridization probe melting analysis; in Meuer S, Wittwer C, Nakagawara K (eds): Rapid Cycle Real-Time PCR: Methods and Applications. Heidelberg, Springer, 2001, pp 11-19.
17. Iwanaga Y, Ono K, Takagi S, Terashima M, Tsutsumi Y, Mannami T, Yasui N, Goto Y, Nonogi H, Iwai N: Association analysis between polymorphisms of the lymphotoxin-alpha gene and myocardial infarction in a Japanese population. Atherosclerosis 2004;172:197-198.
18. Szolnoki Z, Havasi V, Talian G, Bene J, Komlosi K, Somogyvari F, Kondacs A, Szabo M, Fodor L, Bodor A, Melegh B: Lymphotoxin-alpha gene 252G allelic variant is a risk factor for large-vessel-associated ischemic stroke. J Mol Neurosci 2005;27:205-211.
19. Laxton R, Pearce E, Kyriakou T, Ye S: Association of the lymphotoxin-alpha gene Thr26Asn polymorphism with severity of coronary atherosclerosis. Genes Immun 2005;6:539-541.
20. Schreyer SA, Vick CM, LeBoeuf RC: Loss of lymphotoxin-α but not tumor necrosis factor-α reduces atherosclerosis in mice. J Biol Chem 2002;277:12364-12368.
21. Suzuki G, Izumi S, Hakoda M, Takahashi N: LTA 252G allele containing haplotype block is associated with high serum C-reactive protein levels. Atherosclerosis 2004;176:91-94.